Biodesix, Inc.BDSXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+99.3%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

5Y CAGR
+99.3%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
31.5x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202552.17%
2024-112.72%
202349.15%
2022-59.35%
2021-32.09%
20201.66%
2019-22.91%
20180.00%